In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Clinical Trial Update Hot Line III: Updates on risk and outcome
Session

Event : ESC Congress 2013

Topic : Other

  • Session type : Clinical Trial Update
  • Date : 04 September 2013
  • Time : 08:30 - 10:00

12 presentations in this session

PURE-Sodium: Heterogeneity in the associations of urinary sodium and potassium with blood pressure: The PURE sodium study

Event : ESC Congress 2013

  • Session : Clinical Trial Update Hot Line III: Updates on risk and outcome
  • Speaker : A Mente (Hamilton,CA)

PURE-Sodium - Discussant review and panel discussions.

Event : ESC Congress 2013

  • Session : Clinical Trial Update Hot Line III: Updates on risk and outcome

ARCTIC-GENE: ARCTIC-GENE

Event : ESC Congress 2013

  • Session : Clinical Trial Update Hot Line III: Updates on risk and outcome
  • Speaker : JP Collet (Paris,FR)

ARCTIC-GENE - Discussant review and panel discussions.

Event : ESC Congress 2013

  • Session : Clinical Trial Update Hot Line III: Updates on risk and outcome

TASTE: Prospective Registry based Randomized Clinical Trials (RRCT) - a new concept for clinical research

Event : ESC Congress 2013

  • Session : Clinical Trial Update Hot Line III: Updates on risk and outcome
  • Speaker : S James (Uppsala,SE)

TASTE - Discussant review and panel discussions.

Event : ESC Congress 2013

  • Session : Clinical Trial Update Hot Line III: Updates on risk and outcome

AMADEUS: Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillation

Event : ESC Congress 2013

  • Session : Clinical Trial Update Hot Line III: Updates on risk and outcome
  • Speaker : GYH Lip (Liverpool,GB)

AMADEUS - Discussant review and panel discussions.

Event : ESC Congress 2013

  • Session : Clinical Trial Update Hot Line III: Updates on risk and outcome

REGARDS: Optimal blood pressure levels in elderly persons in the reasons for geographic and racial differences in stroke (REGARDS) cohort study

Event : ESC Congress 2013

  • Session : Clinical Trial Update Hot Line III: Updates on risk and outcome
  • Speaker : M Banach (Lodz,PL)

REGARDS - Discussant review and panel discussions.

Event : ESC Congress 2013

  • Session : Clinical Trial Update Hot Line III: Updates on risk and outcome

High-STEACS: High-sensitivity cardiac troponin and the under diagnosis of myocardial infarction in women

Event : ESC Congress 2013

  • Session : Clinical Trial Update Hot Line III: Updates on risk and outcome
  • Speaker : N Mills (Edinburgh,GB)

High-STEACS - Discussant review and panel discussions.

Event : ESC Congress 2013

  • Session : Clinical Trial Update Hot Line III: Updates on risk and outcome

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are